Answer
Maribavir competitively blocks ATP binding to the viral UL97 serine/threonine protein kinase during viral DNA replication, inhibiting phosphotransferase activity and cytomegalovirus DNA replication, maturation, encapsidation and nuclear egress without affecting concatemer maturation.
Sources for this answer
- LIVTENCITY 200 mg film coated tabletsTakeda UK Ltd · emc · SmPC §5.1 Pharmacodynamic properties · Version 5Document updated
Sources checked